Lakefront Biotherapeutics (LKFT)

NASDAQ:LKFT

US Market

LKFT

Lakefront Biotherapeutics

RESEARCH TOOLSreports

Want to see LKFT full AI Analyst Report?

Lakefront Biotherapeutics (LKFT) Ownership - Who Owns Lakefront Biotherapeutics?

549 Followers

Lakefront Biotherapeutics (LKFT) Ownership Overview

1.72% Mutual Funds

25.73% Other Institutional Investors

0.63% ETFs

71.92% Public Companies and

Individual Investors

The ownership structure of Lakefront Biotherapeutics (LKFT) stock is a mix of institutional, retail, and individual investors. Approximately 28.08% of the company’s stock is owned by Institutional Investors, and 71.92% is owned by Public Companies and Individual Investors.

The ownership structure of Lakefront Biotherapeutics (LKFT) stock is a mix of institutional, retail, and individual investors. Approximately 26.36% of the company’s stock is owned by Institutional Investors, 1.72% is owned by Insiders, and 71.92% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$850
Dec 31, 2023	Western Standard Llc	xxxxxxxxxxxxx	$1046400

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	714,747	Institution	1.08%	19,648,395
	288,504	Institution	0.44%	7,930,975
	108,500	Institution	0.16%	2,982,665
	94,266	Institution	0.14%	2,591,372
	94,152	Institution	0.14%	2,588,238
	80,106	Institution	0.12%	2,202,114
	64,708	Institution	0.10%	1,778,823
Theofanis Kolokotrones	50,500	Institution	0.08%	1,388,245
	38,189	Institution	0.06%	1,049,816
	32,701	Institution	0.05%	898,950

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	714,747	Institution	1.08%	19,648,395
	108,500	Institution	0.16%	2,982,665
	94,266	Institution	0.14%	2,591,372
	94,152	Institution	0.14%	2,588,238
	80,106	Institution	0.12%	2,202,114
	32,701	Institution	0.05%	898,950
	7,851	Institution	0.01%	215,824
	1,419	Institution	<0.01%	39,008

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	267,864	Institution	0.41%	7,320,723
ALPS Medical Breakthroughs ETF	64,708	Institution	0.10%	1,768,470
Avantis International Equity ETF	30,449	Institution	0.05%	835,825
ActivePassive International Equity ETF	18,161	Institution	0.03%	498,519
iShares NASDAQ US Biotechnology UCITS ETF	10,320	Institution	0.02%	283,284
Avantis International Small Cap Equity ETF	6,552	Institution	<0.01%	179,066
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD	1,791	Institution	<0.01%	49,163
Invesco Nasdaq Biotechnology ETF	794	Institution	<0.01%	21,700
American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD	569	Institution	<0.01%	15,619
Avantis Global Equity Ucits ETF	569	Institution	<0.01%	15,619

FAQ

Who Owns Lakefront Biotherapeutics (LKFT)?

Currently, no data Available

What percentage of Lakefront Biotherapeutics (LKFT) stock is held by institutional investors?

According to the latest TipRanks data, approximately 25.73% of Lakefront Biotherapeutics (LKFT) stock is held by institutional investors.

What percentage of Lakefront Biotherapeutics (LKFT) stock is held by retail investors?

According to the latest TipRanks data, approximately 71.92% of Lakefront Biotherapeutics (LKFT) stock is held by retail investors.

Who owns the most shares of Lakefront Biotherapeutics (LKFT)?

COLUMBIA FUNDS SERIES TRUST owns the most shares of Lakefront Biotherapeutics (LKFT).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.